Klassen Preston

CIK 00014930566 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001493056

Recent Transactions

50 trades

Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−528,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−120,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−225,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Common Stock
2025-06-25−115,555→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−675,000→ 0 total
Disposition to Issuer
Regulus Therapeutics Inc.
Stock Option
2025-06-25−350,000→ 0 total
Purchase
Regulus Therapeutics Inc.
Common Stock
2025-06-03$7.99/sh+12,000→ 48,055 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2025-01-30+675,000→ 675,000 total
Sale
Regulus Therapeutics Inc.
Common Stock
2025-01-13$1.26/sh−31,445→ 36,055 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-01-09$1.36/sh+37,500→ 37,500 total
Award
Regulus Therapeutics Inc.
Common Stock
2025-01-09$1.30/sh+30,000→ 67,500 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-05-20+528,000→ 528,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2024-01-12+120,000→ 120,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-08-10+225,000→ 225,000 total
Award
Regulus Therapeutics Inc.
Stock Option (Right to Buy)
2023-06-12+350,000→ 350,000 total
Award
Metacrine, Inc.
Common Stock
2023-03-23$0.47/sh−842,211→ 1,384,116 total
Disposition to Issuer
Metacrine, Inc.
Stock Option (right to buy)
2023-03-23−842,211→ 0 total
Sale
Metacrine, Inc.
Common Stock
2023-01-26$0.41/sh−380,605→ 541,905 total
Sale
Metacrine, Inc.
Common Stock
2022-04-19$0.50/sh−43,575→ 923,683 total
Sale
Metacrine, Inc.
Common Stock
2022-04-19$0.51/sh−1,173→ 922,510 total
Award
Metacrine, Inc.
Common Stock
2022-04-14+104,500→ 967,258 total
Award
Metacrine, Inc.
Stock option (right to buy)
2022-02-27+842,211→ 842,211 total
Award
Metacrine, Inc.
Common Stock
2022-02-27+842,211→ 862,758 total
Purchase
Metacrine, Inc.
Common Stock
2021-05-20$3.64/sh+20,547→ 20,547 total
Award
Metacrine, Inc.
Stock Option (Right to Buy)
2021-02-10+247,500→ 247,500 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2020-03-01+70,000→ 70,000 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Common Stock
2019-10-14+6,300→ 6,300 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Performance Restricted Stock Unit
2019-10-14−6,300→ 18,900 total
Tax Payment
ARENA PHARMACEUTICALS INC
Common Stock
2019-10-14$47.32/sh−2,309→ 3,991 total
Award
Histogen Inc.
Stock Option (Right to Buy)
2019-06-27+20,000→ 20,000 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-08−3,000→ 110,350 total
Sale
ARENA PHARMACEUTICALS INC
Common Stock
2019-01-08$44.00/sh−3,000→ 0 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Common Stock
2019-01-08$15.10/sh+3,000→ 3,000 total
Sale
ARENA PHARMACEUTICALS INC
Common Stock
2019-01-07$41.68/sh−15,600→ 400 total
Sale
ARENA PHARMACEUTICALS INC
Common Stock
2019-01-07$42.32/sh−400→ 0 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Common Stock
2019-01-07$15.10/sh+16,000→ 16,000 total
Exercise/Conversion
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-07−16,000→ 113,350 total
Award
ARENA PHARMACEUTICALS INC
Employee Performance Restricted Stock Unit
2019-01-04+12,600→ 12,600 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2019-01-04+75,000→ 75,000 total
Award
Histogen Inc.
Stock Option (Right to Buy)
2018-06-21+20,000→ 20,000 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy)
2018-01-19+130,000→ 130,000 total
Award
Histogen Inc.
Stock Option (Right to Buy)
2017-06-22+20,000→ 20,000 total
Award
ARENA PHARMACEUTICALS INC
Employee Stock Option (right to buy
2017-03-20+1,293,500→ 1,293,500 total
Award
Histogen Inc.
Stock Option (Right to Buy)
2016-06-23+20,000→ 20,000 total
Award
Orexigen Therapeutics, Inc.
Performance Stock Units
2016-02-02+350,000→ 350,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2016-02-02+190,000→ 190,000 total
Award
Orexigen Therapeutics, Inc.
Common Stock
2015-11-30$2.03/sh+4,170→ 10,160 total
Award
Histogen Inc.
Stock Option (Right to Buy)
2015-06-11+15,000→ 15,000 total
Award
Orexigen Therapeutics, Inc.
Common Stock
2015-05-30$4.17/sh+1,860→ 5,990 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2015-02-03+182,650→ 182,650 total

Companies

Recent Filings

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037

View on SEC.gov